Skip to search form
Skip to main content
Semantic Scholar's Logo
Create Free Account
You are currently offline. Some features of the site may not work correctly.
tat Gene Products, Human Immunodeficiency Virus
HIV tat Protein
, Trans Acting Transcription Factor, HIV
, HIV Transacting Transcription Protein
Proteins encoded by the TAT GENES of the HUMAN IMMUNODEFICIENCY VIRUS.
National Institutes of Health
HIV-TAT-survivin (T34A) protein
tat peptide (1-9), Human immunodeficiency virus 1
tat peptide (48-60), Human immunodeficiency virus 1
tat peptide (49-57), Human immunodeficiency virus 1
Process of secretion
antagonists & inhibitors
Semantic Scholar uses AI to extract papers important to this topic.
SCOPE OF CONSTRUCTIVIST APPROACH IN CONCEPT EXPERIMENTAL EVALUATION OF A NEW TEACHING MODEL FOR TRANSACTING VIMSATIGUNA
Corpus ID: 212466422
Background: Reforms in pedagogy of Ayurveda hopefully anticipate its shift from teacher centredness, from directive teaching to…
HIV Tat protein: Is Tat‐C much trickier than Tat‐B?
M. K. Johri
Journal of medical virology
Corpus ID: 206121298
Out of various subtypes of human immunodeficiency virus type 1 (HIV‐1), subtype B and C cause most of the infections worldwide…
Privatisation of public enterprises in COMESA: An exploration of approaches and strategies: the case of the privatization of Telkom Kenya
Reginah Kiti Khatemende Kitiabi
Corpus ID: 155142878
This thesis investigates Kenya's approach to the privatization process through an exploration of Telkom Kenya's (TKL) unfolding…
Fixed-dose combination ( FDC ) drugs availability and use as a global public health necessity : intellectual property and other legal issues
Corpus ID: 15478609
Patented medicines are priced far above marginal cost and patent holders are rewarded for research and development (R&D) with…
Structural basis of the highly efficient trapping of the HIV Tat protein by an RNA aptamer.
Corpus ID: 43415554
An RNA aptamer containing two binding sites exhibits extremely high affinity to the HIV Tat protein. We have determined the…
By clicking accept or continuing to use the site, you agree to the terms outlined in our
Terms of Service
ACCEPT & CONTINUE